Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w, 15g Cream

Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w cream treats steroid-responsive skin inflammation complicated by susceptible bacterial infection. It pairs a very potent topical corticosteroid with an antibiotic.
Apply a thin film to the affected skin after gentle cleaning and drying. Keep away from the eyes, face and skin folds unless those sites are specifically included in the treatment plan. Do not add an airtight covering.
Halobetasol reduces inflammatory signalling through glucocorticoid receptors. Fusidic acid inhibits bacterial protein synthesis by interfering with elongation factor G.
Local stinging, dryness, itching or irritation may occur. Excessive use can cause skin thinning, stretch marks or secondary infection.
A steroid–antibiotic cream does not treat ringworm or viral skin lesions. Repeated courses can select fusidic-acid-resistant bacteria while prolonged steroid exposure damages the skin.
Treats bacterial involvement while reducing the inflammation contributing to redness and soreness.
No. Fungal infection, scabies, contact allergy and eczema without bacterial infection need different approaches.
The antibiotic and potent steroid are intended for a limited course, rather than open-ended maintenance.
Mixing the cream with a moisturiser in your hand changes its concentration and can spread medicine onto unaffected skin. Apply the products separately.
No. A potent steroid can worsen acne and cause additional acne-like bumps.
Not by itself. The steroid can improve itching before the bacterial response is clear.
Superinfection: an additional infection developing in diseased skin. Fusidic acid: an antibiotic used against susceptible bacteria. Elongation factor G: a bacterial protein involved in making new proteins.; AR: Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w كريم; FR: Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w crème; PT: Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w creme; ES: Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w crema; RU: Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w крем; ID: Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w krim; VI: Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w kem bôi; MS: Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w krim; TL: Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w krema; ZH-SG: Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w 乳膏
International B2B Enquiry
Send a structured B2B enquiry for Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w, 15g Cream under Skin Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Halobetasol Propionate 0.05% w/w + Fusidic Acid 2% w/w, 15g Cream